Nektar Therapeutics | Action





Action Changement Date
Agios Pharmaceuticals USD 32.03M 1.19M 2025-09
ALKERMES USD 191M 927K 2025-09
Amgen USD 6.22B 121M 2025-12
Baxter International USD 2.46B 76M 2025-09
BioCryst Pharmaceuticals USD 5.23M 188K 2025-09
Biogen USD 2.17B 41.3M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Cara Therapeutics USD 900K 0 2025-03
Cipla INR 61.6B 5.18B 2025-09
Dr.Reddys Laboratories INR 79.01B 3.19B 2025-12
Eisai JPY 236.46B 9.14B 2025-09
Eli Lilly USD 12.18B 1.17B 2025-09
Esperion Therapeutics USD 108.54M 5.93M 2025-09
Exelixis USD 27.4M 3.92M 2025-09
Gilead Sciences USD 1.78B 40M 2025-09
GlaxoSmithKline GBP 6.12B 46M 2025-09
Grifols EUR 3.56B 63.19M 2024-12
Halozyme Therapeutics USD 185.8M 4.29M 2025-09
Incyte USD 101.06M 17.61M 2025-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
Karyopharm Therapeutics USD 3.97M 1.03M 2025-09
MacroGenics USD 8.75M 530K 2025-09
Merck USD 6.44B 157M 2025-09
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 69.3M 12.4M 2025-09
Novartis USD 6.42B 114M 2025-09
Pfizer USD 11.47B 201M 2025-09
Roche Holding CHF 7.6B 9M 2025-06
Sarepta Therapeutics USD 1.08B 83.13M 2025-09
Takeda JPY 1.41T 107.71B 2025-12
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12


Nektar Therapeutics Action - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.